<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211028052898N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-11-20</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Study of the effect of submucosal and intramuscular injection of dexamethasone before and after mandibular impacted wisdom tooth surgery in reducing postoperative swelling and trismus</public_title>
      <acronym></acronym>
      <scientific_title>Study of the effect of submucosal and intramuscular injection of dexamethasone before and after mandibular impacted wisdom tooth surgery in reducing postoperative swelling and trismus</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59657</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The sampling method is regular random, by random numbers. That is, after examination and approval of patients by a specialist on panoramic graphics, patients were randomly placed in a list of 72 people in order of inclusion in the study. Quadratic numbers starting with 1 in group A, numbers with quadratic interval starting from 2 in group B, numbers with quadratic interval starting from 3 in group C and numbers with quadratic interval starting from 4 in group D, are divided, Blinding description: Only the surgeon, who is injecting the anesthetic and corticosteroids, is aware of the groups of patients. The student who records the level of swelling and trismus of patients is not aware of the patient group and therefore the study is one-sided blind.</study_design>
      <phase>2</phase>
      <hc_freetext>Swelling and trismus after impacted mandibular wisdom tooth surgery.</hc_freetext>
      <i_freetext>Intervention 1: Patients are 18 to 35 years old. All patients have third mandibular molar  surgery in hard tissue. In 4 groups, inferior alveolar nerve and long buccal nerve block is performed with lidocaine. All surgeries are performed by an experienced surgeon with the same technique. Alborz Daroo is the commercial company that produces all dexamethasone. All patients receive 500 mg amoxicillin, 400 mg ibuprofen, and chlorhexidine mouthwash after surgery. All surgeries are performed by a surgeon, and in each surgery the type of flap created is triangular. Intervention group 1: receives 4 mg of intramuscular dexamethasone before surgery. Intervention 2: Intervention group 2: receives 4 mg of intramuscular dexamethasone after surgery. Intervention 3: Intervention group 3: receives 4 mg of submucosal dexamethasone before surgery. Intervention 4: Intervention group 4: receives 4 mg of submucosal dexamethasone after surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as the original outcome information, can be shared.

When:
The access period starts one year after the results are published.

To whom:
The data will be available to all researchers.

Conditions:
Any kind of analysis on the delivered data is allowed.

Where to obtain:
Mehdi Ebrahimi, 09015954041, ebrahimimehdi96@gmail.com

How to obtain:
After submitting the application to the mentioned e-mail address, the documents will be sent to the applicant within one week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehdi Heydarizade</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5th floor - Bouali Building - Khorram Street</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3819748585</zip>
        <telephone>+98 86 3312 8233</telephone>
        <email>ebrahimimehdi96@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehdi Heydarizade</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5th floor - Bouali Building - Khorram Street</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3819748585</zip>
        <telephone>+98 86 3312 8233</telephone>
        <email>ebrahimimehdi96@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with impacted mandibular wisdom teeth who do not have pericoronitis.
Patients with impacted mandibular wisdom teeth who do not have a local infection.
Patients with impacted mandibular wisdom teeth over 18 years of age.
Patients with impacted mandibular wisdom teeth who are not taking antibiotics or anti-inflammatory drugs.
Patients with impacted mandibular wisdom teeth who do not have systemic problems and allergies.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnant people.
People with allergies to the drugs used in the study.
Patients with local infection.
Patients taking antibiotics or anti-inflammatory drugs.
Patients with systemic problems and allergies.
Patients with pericoronitis.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Patients are 18 to 35 years old. All patients have third mandibular molar  surgery in hard tissue. In 4 groups, inferior alveolar nerve and long buccal nerve block is performed with lidocaine. All surgeries are performed by an experienced surgeon with the same technique. Alborz Daroo is the commercial company that produces all dexamethasone. All patients receive 500 mg amoxicillin, 400 mg ibuprofen, and chlorhexidine mouthwash after surgery. All surgeries are performed by a surgeon, and in each surgery the type of flap created is triangular. Intervention group 1: receives 4 mg of intramuscular dexamethasone before surgery.</i_keyword>
      <i_keyword>Intervention group 2: receives 4 mg of intramuscular dexamethasone after surgery.</i_keyword>
      <i_keyword>Intervention group 3: receives 4 mg of submucosal dexamethasone before surgery.</i_keyword>
      <i_keyword>Intervention group 4: receives 4 mg of submucosal dexamethasone after surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Trismus after impacted mandibular wisdom tooth surgery. Timepoint: At the beginning of the study (before the intervention) and 72 hours after the intervention. Method of measurement: Measurement of the boundary line between the incisive edge of the upper and lower incisors at maximum mouth opening by a calibrated ruler.</prim_outcome>
      <prim_outcome>Swelling after mandibular wisdom tooth surgery. Timepoint: At the beginning of the study (before the intervention) and 72 hours after the intervention. Method of measurement: Using a tape measure, the distance between the earlobe to the corner of the mouth (Method A) and the inner corner of the eye to the mandibular angle (Method B).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-02</approval_date>
        <contact_name>Ethics committee of Arak University of Medical Sciences</contact_name>
        <contact_address>13th floor, Block A, Treatment and Medical Education, Central Headquarters of the Ministry of Health, between South Flamek and Zarafshan, Iran TV St, Ghods Town (West), Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
